Update in Asthma and Airway Inflammation 2018

Am J Respir Crit Care Med. 2019 Jul 1;200(1):14-19. doi: 10.1164/rccm.201902-0321UP.

Authors

Andrew Menzies-Gow¹, Claire Nichola McBrien², Jonathan R Baker³, Louise E Donnelly³, Robyn T Cohen⁴

Affiliations

¹ 1 Department of Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom.
² 2 Imperial College London, London, United Kingdom.
³ 3 National Heart and Lung Institute, Imperial College London, London, United Kingdom; and.
⁴ 4 Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts.

PMID: 31026407
DOI: 10.1164/rccm.201902-0321UP

No abstract available

Publication types

Review

MeSH terms

Animals
Anti-Asthmatic Agents / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use
Asthma / diagnostic imaging
Asthma / drug therapy
Asthma / epidemiology
Asthma / immunology*
Disease Models, Animal
Environmental Exposure / statistics & numerical data*
Female
Humans
In Vitro Techniques
Inflammation*
Obesity / epidemiology
Obesity / immunology
Omalizumab / therapeutic use
Particulate Matter
Pneumonia, Mycoplasma / epidemiology
Pneumonia, Mycoplasma / immunology
Pregnancy
Prenatal Exposure Delayed Effects / epidemiology
Prenatal Exposure Delayed Effects / immunology
Respiratory Hypersensitivity / drug therapy
Respiratory Hypersensitivity / epidemiology
Respiratory Hypersensitivity / immunology
Respiratory Mucosa
Sugar-Sweetened Beverages
Vaping

Substances

Anti-Asthmatic Agents
Antibodies, Monoclonal, Humanized
Particulate Matter
Omalizumab
reslizumab
dupilumab
benralizumab
mepolizumab